Journal of the American Oil Chemists Society

, Volume 51, Issue 11, pp 670A–677A | Cite as

Laocs news feature Shortages and regulations: headaches for toilet soap formulators

  • John H. Pickin


The formulator is faced with shortages in soap stock fats and oils and must juggle the merits and costs of less common oils, lower grade greases, and synthetics as substitutes for familiar beef tallow and coconut oil. Best compromises must be made by the perfumer for essential oils no longer obtainable to maintain quality and to preserve the odor image of soap products. The formulator must have in vitro, in vivo, and safety data for soap additives. All through development, the formulator must remember that, having made it, he must prove it. Efficacy tests must be more detailed and closer and closer to life.


Federal Trade Commission Drug Ingredient Toilet Soap Benzyl Acetate Soap Formulator 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


  1. 1.
    Webb, E.T., “Soap and Glycerine Manufacturing,” Davis Brothers, London, England, 1927, P. 106.Google Scholar
  2. 2.
    Glenn, J., Soap 14:21 (1938).Google Scholar
  3. 3.
    Poucher, W.A., “Perfumes, Cosmetics and Soap,” Vol. II, Chapman and Hall, London, England, 1959, p. 344.Google Scholar
  4. 4.
    Billot, M., Soap Perfum. Cosmet, 40:241 (1967).Google Scholar
  5. 5.
    Anonymous, “F-D-C Reports,” 36:32 (1974).Google Scholar
  6. 6.
    Poucher, W.A., “Perfumes, Cosmetics and Soap,” Vol. I, Chapman and Hall, London, England, 1959, p. 70.Google Scholar
  7. 7.
    Udell, G.G., “Federal Food, Drug, and Cosmetic Act with Amendments,” U.S. Government Printing Office, Washington, D.C., 1970, p. 12.Google Scholar
  8. 8.
    Udell, G.G., Ibid.“ p. 83.Google Scholar
  9. 9.
    Udell, G.G., Ibid.,“ p. 86.Google Scholar
  10. 10.
    Anonymous, “Hazardous Substances, Regulations under the Federal Hazardous Substances Labeling Act, Aug. 12, 1961,” U.S. Department of Health, Education, and Welfare, Food and Drug Administration, Washington, D.C., 1962, p. 2.Google Scholar
  11. 11.
    Goldenthal, E.I., “Guidelines for Reproduction Studies for Safety Evaluation of Drugs for Human Use,” Food and Drug Administration, Washington, D.C., March 1, 1966.Google Scholar
  12. 12.
    Schmidt, A.M., “Federal Register,” 38:31261 (1973).Google Scholar
  13. 13.
    Anonymous, “F-D-C Reports,” 35:18 (1973).Google Scholar

Copyright information

© American Oil Chemists’ Society 1974

Authors and Affiliations

  • John H. Pickin
    • 1
  1. 1.Research and Development DepartmentColgate-Palmolive CompanyPiscataway

Personalised recommendations